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SUMMARY
Sleep paralysis is a relatively common but under-researched phenom-
enon. In this paper we examine prevalence in a UK sample and
associations with candidate risk factors. This is the ﬁrst study to
investigate the heritability of sleep paralysis in a twin sample and to
explore genetic associations between sleep paralysis and a number of
circadian expressed single nucleotide polymorphisms. Analyses are
based on data from the Genesis1219 twin/sibling study, a community
sample of twins/siblings from England and Wales. In total, data from 862
participants aged 22–32 years (34% male) were used in the study. This
sample consisted of monozygotic and dizygotic twins and siblings. It was
found that self-reports of general sleep quality, anxiety symptoms and
exposure to threatening events were all associated independently with
sleep paralysis. There was moderate genetic inﬂuence on sleep
paralysis (53%). Polymorphisms in the PER2 gene were associated
with sleep paralysis in additive and dominant models of inheritance—
although signiﬁcance was not reached once a Bonferroni correction was
applied. It is concluded that factors associated with disrupted sleep
cycles appear to be associated with sleep paralysis. In this sample of
young adults, sleep paralysis was moderately heritable. Future work
should examine speciﬁc polymorphisms associated with differences in
circadian rhythms and sleep homeostasis further in association with
sleep paralysis.
INTRODUCTION
Sleep paralysis involves a period of inability to perform
voluntary movements at either sleep onset or upon awaken-
ing (International Classiﬁcation of Sleep Disorders, Third
Edition, American Academy of Sleep Medicine, 2014). Sleep
paralysis is often accompanied by a wide range of terrifying
hallucinations (French and Santomauro, 2007). One system-
atic review suggested that 7.6% of individuals experienced
sleep paralysis at least once in their lives, although individual
estimates range widely between 2 and 60% (Sharpless and
Barber, 2011). In the literature there is a distinction between
sleep paralysis and isolated sleep paralysis (Sharpless et al.,
2010). Sleep paralysis is a common symptom of narcolepsy.
In those with narcolepsy, sleep paralysis may not occur
independently of narcolepsy. When sleep paralysis occurs
outside narcolepsy, it is termed ‘isolated sleep paralysis’
(Sharpless and Grom, 2014). As we were unable to rule out a
narcolepsy diagnosis in our sample, we refrain from using the
term isolated sleep paralysis.
The physiological mechanisms underlying sleep paralysis
are unknown. Experimental evidence implicates disruption to
the sleep cycle as a risk factor (Takeuchi et al., 2002).
Furthermore, self-reported sleep difﬁculties and consumption
of alcohol, known to disrupt sleep, have both been associ-
ated with sleep paralysis (Munezawa et al., 2011). Epidemi-
ological evidence also indicates that sleep paralysis is
associated with anxiety disorders, self-report levels of
depression and exposure to trauma (Mellman et al., 2008;
Ramsawh et al., 2009; Szklo-Coxe et al., 2007).
Risk for sleep paralysis may, in part, be genetic. Currently,
the role of genetic inﬂuences on sleep paralysis is unknown.
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Previous research has shown sleep paralysis to be familial.
In one study of a single family, it was found that within the 64
members studied, 33 of them reported at least one sleep
paralysis experience (Bell et al., 1986). In a second family
study of frequent sleep paralysis sufferers, 19 of the 22
individuals investigated self-reported sleep paralysis (Dahlitz
and Parkes, 1993). While traditional family studies are able to
demonstrate that traits run within families, they are not able to
show whether similarity within family members comes from
genetic or environmental factors (Plomin et al., 2013).
The present research uses a twin study to extend this
literature in three ways. First, we examine concurrent
associations between sleep paralysis and a range of
potential risk factors. The measures are chosen based on
previous literature on risk factors for sleep paralysis (outlined
above). They are general sleep quality, anxiety symptoms,
depressed mood, exposure to threatening events and weekly
alcohol intake. We also examined smoking behaviour and
caffeine intake as potential risk factors for sleep paralysis, on
the basis that nicotine and caffeine have been linked to poor
sleep quality (Karacan et al., 1976; Phillips and Danner,
1995). By looking at multiple variables simultaneously, we will
be able to identify those associated independently with sleep
paralysis.
Secondly, this is the ﬁrst study to investigate genetic and
environmental inﬂuences on sleep paralysis using a classical
twin study design. Using this method, it is possible to
estimate the extent of both genetic and environmental
inﬂuences on sleep paralysis (Plomin et al., 2013). Thirdly,
we investigate associations between sleep paralysis and 15
previously genotyped single nucleotide polymorphisms
(SNPs). We focus on genes that have been investigated
previously either in a sleep genomewide association study
(GWAS) replication study or in a study investigating the role
of genetic variation in circadian candidate genes involved in
sleep homeostasis (see Parsons et al., 2013, 2014).
Table 1 summarizes the SNPs investigated here and their
previous associations. The genes selected for inclusion have
been linked to sleep/circadian cycles. Disruption to these
cycles may be a risk for sleep paralysis, as deliberately
induced sleep disruptions result in an increased frequency of
sleep paralysis episodes (Takeuchi et al., 2002). A number of
these SNPs have been linked to differences in diurnal
preferences. Associations between sleep paralysis episodes
and the time during sleep in which occur have been reported
(Cheyne, 2002). Based on this, it may be that genetic
variation in an individual’s preference of timing of the sleep–
wake cycle might be involved in sleep paralysis.
METHOD
Participants
The present analyses used data from wave 5 of the G1219
longitudinal twin study (McAdams et al., 2013), the only wave
at which sleep paralysis has been assessed. At wave 5,
research assistants attempted to trace those who partici-
pated at wave 4 and their siblings (n = 1817). Following
tracing, all 1817 participants were sent a 12-page question-
naire booklet to complete. Overall, 883 booklets were
completed. For full details on wave 5, see elsewhere (Barclay
et al., submitted).
Zygosity was established through a parent-reported ques-
tionnaire at waves 2 and 3, assessing physical similarity
Table 1 Summary of investigated SNPs
Gene SNP ID Allele
Genotypic frequency
Related phenotypeM/M M/m m/m
PERI rs2735611 T/C 419 129 14 Diurnal preference (Carpen et al., 2006)
PER2 rs934945 G/A 362 175 26 Diurnal preference (Carpen et al., 2006)
PER2 rs2304672 C/G 481 85 1 Diurnal preference/sleep duration/sleep
quality (Carpen et al., 2006;
Parsons et al., 2014)
PER3 rs2797687 C/A 361 164 19 Delayed sleep phase disorder (DSPD).
Archer et al., 2003)
PER3 rs10462020 T/G 355 164 43 Diurnal preference (Parsons et al., 2014)
ABCC9 rs11046211 C/T 503 60 1 Sleep duration (Allebrandt et al., 2013)
ABCC9 rs11046209 A/T 505 60 1 Sleep duration (Allebrandt et al., 2013)
ABCC9 rs11046205 G/A 366 173 21 Sleep duration (Allebrandt et al., 2013)
CACNA1C rs7304986 T/C 542 25 1 Sleep latency (Bryne et al., 2013)
CACNA1C rs16929277 C/G 530 27 1 Sleep quality/sleep latency (Parsons et al., 2013)
CACNA1C rs2302729 C/T 382 169 5 Sleep quality (Bryne et al., 2013)
ARNTL2 rs922270 T/C 414 143 12 Worse evening mood/diurnal preference
(Parsons et al., 2014; Shi et al., 2010)
DBP rs3848543 C/T 400 138 9 Worse evening mood (Shi et al., 2010)
CLOCK rs2070062 T/G 304 214 48 Diurnal preference (Pedrazzoli et al., 2007)
GNb3 rs5443 C/T 285 230 52 Sleep quality (Parsons et al., 2014)
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between twins (Cohen et al., 1975). When zygosity was
available on only one or other wave, this rating was used. If
there was disagreement between zygosity ratings at the two
waves, DNA was obtained (n = 26 pairs) before ﬁnal clas-
siﬁcations were made. The total sample included in these
analyses was 862 individuals. The mean age was
25.30 years [standard deviation (SD): 1.81, range: 22–
32 years] and 66% of the sample were female. Individuals
from 467 families: 118 monozygotic (MZ) twin pairs (105
complete), 222 dizygotic (DZ) twin pairs (182 complete) and
127 sibling pairs (91 complete). Zygosity type was unknown
for 17 individuals.
Ethical approval for different stages of this study has been
provided by the Research Ethics Committees of the Institute
of Psychiatry, South London and Maudsley NHS Trust, and
Goldsmiths, University of London.
Measures
Sleep paralysis
Sleep paralysis was measured by a single item: ‘Sometimes,
when falling asleep or waking up from sleep, I experience a
brief period during which I feel I am unable to move, even
though I think I am awake and conscious of my surround-
ings’. This item has been used in other work (Cheyne et al.,
1999). Responses were on a seven-point scale, ranging from
never to several times a week. The label ‘sleep paralysis’ was
not used, as labelling the experience can affect reported
prevalence rate (Fukuda, 1993).
Sleep quality
Sleep quality was assessed using the Pittsburgh Sleep
Quality Index (PSQI) (Buysse et al., 1989). This 18-item
questionnaire assesses seven components of sleep quality
and disturbances (sleep duration, sleep disturbance, sleep
latency, daytime dysfunction due to sleepiness, sleep efﬁ-
ciency, overall sleep quality and use of sleep medication).
The global score has a theoretical range of 0–21, with a
higher score indicating higher levels of sleep problems. The
scale had a reliability of a = 0.71.
Anxiety symptoms
The Revised Symptoms of Anxiety Scale was used to
measure anxiety in the present sample (Tom Willis, unpub-
lished). This is a revised version of the Revised Child Anxiety
and Depression Scale (Chorpita et al., 2000), adapted for
use in longitudinal studies of anxiety in early adulthood. It is a
36-item questionnaire yielding a total anxiety score. Partic-
ipants are asked how often each item happens to them.
Responses to each item are made on a four-point scale
(never, sometimes, often and always). The theoretical range
of scores was 0–108, and a higher score indicates greater
anxiety. The scale had a reliability of a = 0.94.
Depressed mood
The Moods and Feelings Questionnaire (MFQ) is a 13-item
questionnaire (Angold et al., 1995). Items ask how partici-
pants have been feeling or acting during the last 2 weeks.
Responses to each item are on a three-point scale (not true,
sometimes and true). It has a theoretical range of 0–26, and
yields a single global score measuring the core symptom-
atology of depression. A higher score indicates more
depressive symptoms. The scale had a reliability of a = 0.90.
Threatening life events
Experience of threatening events during the last 12 months
was measured using a list of 24 threatening life events
(Brugha et al., 1985; Coddington and Humphrey, 1984).
Examples of events include having been in hospital with a
serious illness or injury or having had problems with the
police or court appearance. A global score was calculated by
tallying individual events experienced by each participant. A
higher score indicated exposure to a greater number of
potentially threatening events in the last 12 months. The
theoretical range was 0–24 and had a reliability of a = 0.67.
Substance use
Measures of alcohol and smoking behaviour were based on
previously used scales (Currie et al., 2008). Alcohol intake
was assessed by four items: (1) ‘Do you drink?’; (2) ‘When
you have an alcoholic drink, how many drinks do you have?’
[scale ranged from one to eight or more, with one alcoholic
drink being ½ pint beer or lager/one glass of wine/one glass
of spirits, or one ‘alcopop’ (a ready-mixed drink that resem-
bles a soft drink but contains alcohol—deﬁnition not given to
participants)]; (3) ‘How often do you have an alcoholic drink’?
(once or twice a year, once or twice in 6 months, once or
twice a month, once or twice a week, three or four times a
week, ﬁve or six times a week, almost every day); and (4)
‘During the last 30 days, how many times did you have ﬁve or
more drinks on the same occasion?’ (four or more times,
three times, twice, once, I have not had ﬁve or more drinks on
the same occasion in the past month, I have never had ﬁve or
more drinks on the same occasion). Using items 2–4,
average alcohol intake in terms of units of alcohol consumed
per week was calculated.
Smoking behaviour was assessed by three items: ‘Do you
smoke?’, ‘How often do you smoke cigarettes?’ (every day,
twice a week, once a week, once a fortnight and once a
month) and ‘On the days that I do smoke, I smoke. . .’ (one-
ﬁve cigarettes, six–10 cigarettes, 11–15 cigarettes, 16–20
cigarettes, more than 20 cigarettes). The latter two questions
were then used to calculate the number of cigarettes smoked
per week.
The number of caffeinated drinks consumed per day for the
last month was assessed (Kendler and Prescott, 1999). The
drinks considered were: freshly brewed coffee (one shot
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espresso = one cup), instant coffee, caffeinated tea, and
caffeinated soft drinks, and the numbers of each drink type
consumed ranged from 0 to 8 or more. The number of each
drink type consumed was recoded to reﬂect the amount of
caffeine present in each type of drink. By adding together
the score for each drink type, total caffeine intake was
calculated.
Genetic analyses
The classical twin method
Twin studies compare within-pair similarity for groups of MZ
twins, who are genetically identical, and DZ twins, who share
on average half their segregating genes. This information can
be used to estimate additive genetic (A), dominant genetic
(D), shared environmental (C) and non-shared environmental
(E) inﬂuences on a trait (Plomin et al., 2013). Additive genetic
inﬂuences refer to individual differences in a phenotype
inﬂuenced by the additive effect of independent alleles.
Dominant genetic inﬂuences are when the inﬂuence of one
allele interacts with another at a locus to inﬂuence behaviour.
Shared environmental inﬂuences make individuals within a
family more similar, and non-shared environmental inﬂu-
ences make individuals within a family less similar, and also
account for error. It is not possible to estimate dominant
genetic and shared environmental inﬂuences in the same
model, so either an ACE or ADE model can be ﬁtted to the
data. More detailed coverage of the classical twin design is
available elsewhere (Plomin et al., 2013).
DNA extraction and genotyping
Cheek swab kits were posted to participants in order to
collect DNA, primarily during wave 4; see elsewhere for a
detailed description of DNA extractions (Barclay et al., 2011).
Fifteen SNPs were genotyped (see Table 1). The SNPs
rs11046209 and rs11046211 as well as rs16929277 and
rs7304986 were proxies for each other and were included as
technical replicates. All the genotyping assays were per-
formed by KBioscience using KASPar chemistry; for more
details see elsewhere (LGC Genomics, 2014). Blind dupli-
cates and Hardy–Weinberg equilibrium (HWE) tests were
used as quality control tests (Turner et al., 2011). Linkage
disequilibrium (LD) and HWE were calculated using the
Haploview program (Barrett et al., 2005). Both the proxy
pairs were in complete LD with each other (R2 = 1), so one
SNP from each pair was included in the analysis
(rs11046209 and rs16929277, respectively). The SNPs
rs10462020 (v2 = 13.74, P = 0.0004) and rs2302729
(v2 = 8.73, P = 0.0025) failed to reach HWE and were
therefore dropped from the analyses. All other SNPs were
in HWE at the threshold of P < 0.05. The SNPs rs934945
and rs2304672 occurred in the same gene (PER2), and were
not in LD with each other (v2 = 6.82, P = 0.004). The SNPs
rs11046209 and rs11046205 also occurred in the same gene
(ABCC9), and were not in LD with each other (v2 = 25.55,
P < 0.001).
Statistical analyses
The sleep paralysis measure was heavily positively skewed
(skew = 1.93). As transforming the variable was not able to
improve the distribution sufﬁciently, the variable was dichot-
omized into sleep paralysis absent = 0 and sleep paralysis
present = 1. Participants who had experienced sleep paral-
ysis at least once or more in their lives were categorized as
sleep paralysis present. All analyses were performed on the
dichotomized variable. Age and sex were controlled in all
analyses. Phenotypic and molecular genetic analyses were
carried out using Stata 9 (StataCorp, 2005). The Stata
command ‘cluster’ was used in order for the tests to be robust
against the non-independence of observations found in the
twin sample. Logistic regression was used to explore
associations between variables, and all continuous predictors
were standardized. Cases with missing data were removed
prior to analysis. Twin analysis was carried out using
OpenMx (Boker et al., 2011). The sleep paralysis variable
was analysed using a univariate threshold liability model.
Logistic regression analyses were conducted to model the
main effect of SNPs on sleep paralysis. Three non-indepen-
dent models of inheritance were investigated: additive,
dominant and recessive. The P-value was adjusted by using
the total number of SNPs investigated for sleep paralysis,
thus the corrected P-values are P = 0.05/11 = 0.0045. We
did not apply corrections for multiple testing for the number of
inheritance models that we ran (additive, dominant, and
recessive), as these tests were not independent of each
other.
RESULTS
Prevalence of SP
Descriptive statistics for all variables are provided in Table 2.
Of the sample, 29.7% reported experiencing sleep paralysis
at least once in their lives. A smaller percentage, 7.9%,
reported experiencing sleep paralysis several times a year.
The distribution of sleep paralysis scores is displayed in
Fig. 1. Using the dichotomous sleep paralysis measure there
were no sex differences, but there was a signiﬁcant relation-
ship between sleep paralysis and age (see Table 3).
Phenotypic analysis
The correlation matrix for all variables is displayed in Table 2.
Results of the logistic regression models are displayed in
Table 3. In age- and sex-controlled single predictor models,
all the variables except for smoking behaviour and caffeine
intake were associated signiﬁcantly with sleep paralysis. All
the variables associated signiﬁcantly with sleep paralysis in
single predictor models (sleep quality, anxiety symptoms,
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depressed mood, exposure to threatening events and alcohol
intake) were entered into the multiple predictor model to test
associations simultaneously. In this model, sleep quality,
anxiety symptoms and exposure to threatening events were
associated signiﬁcantly with sleep paralysis.
Univariate twin model
Tetrachoric twin correlations for sleep paralysis were higher
for MZ (rt = 0.56) than DZ (rt = 0.004) twins. Furthermore,
MZ correlations were higher than sibling correlations
(rt = 0.15). Fisher’s r–z transform was used to establish
whether the differences between the magnitude of the
correlations were signiﬁcant (Kenny, 1987). The MZ twin
correlations were signiﬁcantly higher than the DZ twins
(z = 13.67, P < 0.001). MZ correlations were also signiﬁ-
cantly higher than siblings (z = 9.66, P < 0.001).
This pattern of results suggests a heritable component.
Dominant genetic inﬂuence was implied, as the MZ correla-
tions were more than double the DZ correlation (Plomin et al.,
2013). The fact that the DZ correlation was near zero
suggests that no additive genetic or shared environmental
components were involved in explaining variation in sleep
paralysis.
In line with the twin correlations, an ADE threshold liability
model provided a good ﬁt. There was a non-signiﬁcant
deterioration in ﬁt when compared to the saturated model
(2LL = 1529.4, df = 1250, P = 0.32). The model estimated:
A = 0.00 [95% conﬁdence interval (CI): 0.00–0.47]; D = 0.53
(95% CI: 0.00–0.70); E = 0.47 (95% CI: 0.30–0.68). The ﬁt of
a submodel was then tested by dropping the A and D
components, thus testing the importance of genetic effects in
explaining the sleep paralysis phenotype. This model showed
a signiﬁcant deterioration in ﬁt, compared to the full ADE
Table 2 Descriptive statistics and correlations matrix for all variables assessed in the study
Variable Mean (SD)
Sleep
paralysis
Sleep
quality Anxiety Depression
Threatening
events Alcohol
Smoking
behaviour Caffeine
Sleep paralysis 1.67 (1.16) 1.00
Sleep quality 5.38 (5.30) 0.24*** 1.00
Anxiety symptoms 22.13 (14.81) 0.28*** 0.35*** 1.00
Depressed mood 5.31 (5.30) 0.28*** 0.45*** 0.64*** 1.00
Threatening events 1.92 (2.13) 0.21*** 0.26*** 0.17*** 0.30*** 1.00
Alcohol 5.91 (7.38) 0.08* 0.02 0.08* 0.01 0.09* 1.00
Smoking behaviour 7.00 (22.20) 0.16*** 0.11** 0.10** 0.18*** 0.25* 0.20*** 1.00
Caffeine 7.71 (8.00) 0.04 0.09* 0.07* 0.12** 0.10** 0.18*** 0.18*** 1.00
* = p < .05, ** = p < .01, *** = p < .001
Figure 1. Histogram showing the distribution of sleep paralysis
frequency in the current sample.
Table 3 Associations of standardised predictor scores with sleep
paralysis
Variable
Single predictor
models
Multiple predictor
model
OR (CI) SE OR (CI) SE
Sleep quality 1.68***
(1.42–1.98)
0.14 1.28*
(1.05–1.56)
0.13
Anxiety symptoms 1.76***
(1.51–2.05)
0.14 1.39**
(1.13–1.71)
0.15
Depressed mood 1 82***
(1.54–2.14)
0.15 1.23
(0.99–1.53)
0.14
Threatening events 1.53***
(1.30–1.79)
0.12 1.29**
(1.08–1.54)
0.11
Alcohol 1.16*
(1.00–1.33)
0.08 1.12
(0.95–1.32)
0.10
Smoking behaviour 1.15
(0.99–1.33)
0.09
Caffeine 1.08
(0.93–1.25)
0.08
Age 0.88**
(0.81–0.96)
0.04
Sex 1.09
(0.78–1.52)
0.17
OR, odds ratio; CI, conﬁdence interval; SE, standard error.
* = p < .05, ** = p < .01, *** = p < .001
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model (2LL = 1551.5, df = 1252, P < 0.001), highlighting
the importance of genetic inﬂuences on sleep paralysis.
SNP associations with sleep paralysis
The genotypic frequencies for the investigated SNPs are
presented in Table 1. The mean sleep paralysis scores by
genotype are displayed in Table 4. Odds ratios (ORs) for all
SNPs are displayed in Table 5.
Using a standard approach to signiﬁcance testing, there
was a signiﬁcant association between the PER2 SNP
rs2304672 and sleep paralysis using an additive model of
inheritance (P = 0.008) and a dominant model of inheritance
(P = 0.04). The relationship remained signiﬁcant in the
additive model when a single individual with the rare GG
genotype was removed from the data set (P = 0.02). The
other PER2 SNP investigated (rs934945) was not in LD with
this SNP, so no association between the two SNPs was
expected. None of the associations remained signiﬁcant
once the Bonferoni correction was applied (P = 0.0045).
DISCUSSION
In this large-scale community sample, approximately one-
third of participants reported experiencing sleep paralysis at
least once in their lives. This is, to our knowledge, the ﬁrst
prevalence estimate of sleep paralysis in UK residents, and is
higher than a recent review paper suggesting that sleep
paralysis occurs in only 7.6% of the general population
(Sharpless and Barber, 2011). However, we found a similar
prevalence estimate to other research using the same item to
measure sleep paralysis (Cheyne et al., 1999).
The phenotypic analyses showed that sleep quality,
anxiety and exposure to threatening events were related
independently to sleep paralysis. Smoking behaviour and
caffeine intake were not associated signiﬁcantly with sleep
paralysis. Alcohol intake and depressed mood were associ-
ated signiﬁcantly with sleep paralysis when considered in
isolation, but not when considered with multiple variables,
suggesting that they are not unique predictors of sleep
paralysis.
Table 4 Means and standard deviations of sleep paralysis by genotype
Gene SNP Genotype Total Mean (SD) Males Mean (SD) Females Mean (SD)
PER1 rs2735611 TT 1.68 (1.21) 1.62 (1.13) 1.70 (1.25)
TC 1.47 (0.93) 1.45 (0.96) 1.48 (1.25)
CC 1.64 (0.93) 1.66 (1.15) 1.63 (0.92)
PER2 rs934945 GG 1.62 (1.11) 1.64 (1.15) 1.60 (1.08)
GA 1.70 (1.25) 1.43 (0.88) 1.84 (1.38)
AA 1.43 (0.95) 1.73 (1.27) 1.20 (0.56)
PER2 rs2304672 CC 1.57 (1.09) 1.53 (0.97) 1.60 (1.16)
CG 1.85 (1.28) 1.81 (1.60) 1.86 (1.22)
GG 5.00 () 5.00 () –
PER3 rs2797687 CC 1.63 (1.15) 1.61 (1.10) 1.64 (1.17)
CA 1.55 (1.10) 1.47 (0.96) 1.60 (1.18)
AA 1.95 (1.08) 1.66 (1.03) 2.08 (1.12)
ABCC9 rs11046209 AA 1.60 (1.10) 1.57 (1.06) 1.63 (1.13)
AT 1.80 (1.36) 1.50 (1.10) 1.97 (1.48)
TT 1.00 () – 1.00 ()
ABCC9 rs11046205 GG 1.61 (1.15) 1.57 (1.10) 1.64 (1.18)
GA 1.65 (1.13) 1.65 (1.08) 1.65 (1.16)
AA 1.66 (1.24) 1.38 (1.06) 1.85 (1.34)
CACNA1C rs16929277 CC 1.62 (1.14) 1.59 (1.08) 1.64 (1.17)
CG 1.60 (1.15) 1.27 (0.80) 2.00 (1.41)
GG 1.00 () – 1.00 ()
ARNTL2 rs922270 TT 1.65 (1.16) 1.56 (1.03) 1.71 (1.24)
TC 1.54 (1.08) 1.62 (1.25) 1.51 (1.01)
CC 1.75 (1.22) 2.50 (2.12) 1.60 (1.07)
CLOCK rs2070062 TT 1.61 (1.16) 1.41 (0.95) 1.71 (1.25)
TG 1.61 (1.07) 1.68 (1.09) 1.57 (1.07)
GG 1.80 (1.21) 2.00 (1.45) 1.64 (1.13)
DBP rs3848543 CC 1.64 (1.15) 1.57 (1.07) 1.67 (1.19)
CT 1.51 (1.03) 1.53 (1.02) 1.51 (1.03)
TT 2.11 (1.62) 1.67 (0.58) 2.33 (1.97)
GNb3 rs5443 CC 1.62 (1.14) 1.55 (1.13) 1.65 (1.14)
CT 1.62 (1.23) 1.58 (1.02) 1.64 (1.20)
TT 1.70 (1.23) 1.60 (1.06) 1.74 (1.30)
SD, standard deviation.
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These ﬁndings are in line with previous research. Sleep
paralysis has been shown to be associated with higher
levels of self-reported stress and trauma (Mellman et al.,
2008). Similarly, our ﬁndings support previous research
linking anxiety to sleep paralysis (Ramsawh et al., 2009).
Our results did not ﬁnd any independent association
between sleep paralysis and depressed mood, contrary to
other research (Szklo-Coxe et al., 2007). This may be due to
the higher number of predictor variables included in this
study that showed an independent relationship with sleep
paralysis.
This is the ﬁrst twin study investigating the aetiology of
sleep paralysis. Removing the genetic components from the
model led to a signiﬁcant deterioration in model ﬁt, suggest-
ing that genetic effects are important in explaining individual
differences for experiencing sleep paralysis.
Based on the heritability indicated by the twin analyses, we
examined the role of speciﬁc genes for which variation had
been measured in the G1219 sample. This is the ﬁrst study to
our knowledge to look at associations between gene poly-
morphisms and sleep paralysis. We found that variation in the
PER2 gene was associated with sleep paralysis in additive
and dominant models, although not when Bonferroni correc-
tion was applied. The PER2 gene is one of several ‘clock’
genes that govern circadian rhythms, and act as regulators of
the molecular clock. Variations in this gene in humans have
also been linked to differences in diurnal preference (Parsons
et al., 2014). Here we found that variation in this gene is also
associated with sleep paralysis, although not when a Bon-
ferroni correction was applied. If a signiﬁcant association is
found in future studies, this would suggest that variation in
sleep and circadian genes partially underlie the inheritance
seen for sleep paralysis in the twin analysis.
Limitations
The results need to be considered alongside limitations. First,
when considering the phenotypic analyses it is important to
note that the data were cross-sectional, preventing conclu-
sions about the direction of effects. It is therefore possible
that sleep paralysis could have led to other symptoms (e.g.
anxiety) or that a third phenotype could have inﬂuenced both
sleep paralysis and the associated factor. It should also be
considered that all the data were based on self-report
measures.
In the twin analysis, given the small sample size relative to
many behavioural genetic studies and the use of a dichot-
omous sleep paralysis variable, it would be unwise to
distinguish between additive and dominant genetic effects.
Instead, it may be more sensible to interpret this ﬁnding in
terms of broad sense heritability. As well as the small sample
size, the relatively young age of participants in the sample
(range: 22–32) may make it difﬁcult to generalize the ﬁndings
to other age groups.
In the molecular genetic analysis, selection of candidate
genes was exploratory, meaning that a large Bonferroni
correction was applied to control for the multiple compari-
sons, increasing the chances of false negatives occurring.
However, this approach is justiﬁed, because there is no
previous research investigating genes associated with sleep
paralysis. Future work should aim to replicate and extend
these ﬁndings in a larger sample, and using alternative
approaches such as GWAS.
CONCLUSIONS
In conclusion, anxiety symptoms, exposure to threatening
events and general sleep quality are all independent predic-
tors of sleep paralysis. Sleep paralysis appears to have a
genetic component, and future work should attempt to
identify candidate genes which may be involved. While
replication of these ﬁndings is necessary, it is hoped that this
preliminary work will encourage further investigation of the
genetics of sleep paralysis.
Table 5 Odds ratios from logistic regression analysis for main
effects of genotype on sleep paralysis measure
Gene SNP Model Odds ratio (SE)
PER1 rs2735611 Additive 0.87 (0.17)
Recessive 1.43 (0.76)
Dominant 0.02 (0.47)
PER2 rs934945 Additive 0.97 (0.15)
Recessive 0.74 (0.34)
Dominant 1.02 (0.19)
PER2 rs2304672 Additive 1.88 (0.45)**
Recessive –
Dominant 1.84 (0.45)*
PER3 rs2797687 Additive 1.03 (0.18)
Recessive 2.35 (1.04)
Dominant 0.90 (0.18)
ABCC9 rs11046205 Additive 2.06 (0.18)
Recessive 0.78 (0.46)
Dominant 1.13 (0.22)
ABCC9 rs11046209 Additive 1.13 (0.33)
Recessive –
Dominant 1.17 (0.35)
CACNA1C rs16929277 Additive 0.84 (0.35)
Recessive –
Dominant 0.87 (0.38)
ARNTL2 rs922270 Additive 0.84 (0.16)
Recessive 1.27 (0.66)
Dominant 0.78 (0.16)
CLOCK rs2070062 Additive 1.13 (0.16)
Recessive 1.38 (0.40)
Dominant 1.13 (0.21)
DBP rs3848543 Additive 0.97 (0.19)
Recessive 3.18 (1.89)
Dominant 0.86 (0.18)
GNb3 rs5443 Additive 1.05 (0.15)
Recessive 1.06 (0.33)
Dominant 1.06 (0.20)
SE, standard error. * = p < .05, ** = p < .01
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